Back

long term follow up of Implantable Cardioverter Defibrillators (ICD) in hypertrophic cardiomyopathy: is subcutaneous the way forward?

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Subcutaneous and extravascular defibrillators: already mainstream? Implantable Cardioverter-Defibrillator (ICD) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Christopher Monkhouse

Barts Heart Centre, London (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Equal performance of the subcutaneous and transvenous implantable cardioverter defibrillator across all age groups in the PRAETORIAN trial
Miss S. Pepplinkhuizen (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Defibrillation success with a second generation intercostal extravascular ICD lead and commercially available left pectoral pulse generator
Doctor M. Burke (Chicago, US)
Abstract Slides Video
Presentation thumbnail
A comparative analysis of conduction system pacing and biventricular pacing in patients undergoing atrioventricular node ablation: a systematic review and meta-analysis
Doctor H. Eldeeb (Bristol, GB)
Abstract Slides Video
Presentation thumbnail
Sex differences in shocks and device-related complications in subcutaneous implantable-cardioverter defibrillator patients
Ms J. De Veld (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Antithrombotic therapy and the risk of pocket hematoma after subcutaneous implantable cardioverter-defibrillator implantation
Miss S. Pepplinkhuizen (Amsterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Subcutaneous and extravascular defibrillators: already mainstream?

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Evaluating subcutaneous implantable cardioverter defibrillators in hypertrophic cardiomyopathy: fewer complications without increased therapies
thumbnail
Congress Presentation
Subcutaneous versus transvenous implantable cardioverter-defibrillator therapy: real world data from a Portuguese cohort
thumbnail
Congress Presentation
Subcutaneous implantable cardioverter defibrillator: a real world 9 years experience of a portuguese centre

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources